La COVID-19 y la vacuna contra la influenza 5 [imagem]
Date:
31/03/2021
Imagen animada con información sobre la prevención de la influenza mediante la vacunación.
See more details
Risk Groups, Pandemics/prevention & control, Health Promotion, Immunization Programs, Influenza, Human/immunology, Influenza Vaccines/immunology, COVID-19
COVID-19 and Influenza live Q&A with Dr Sylvie Briand and Ann Moen. Ask WHO of 3 November 2020
Date:
03/11/2020
#AskWHO series: This live discussion on 21 October 2020 was about personal, mental, economic and working consequences of the COVID-19 pandemic, between Dr Mike Ryan, Executive Director of the WHO Health Emergencies Programme, and Dr Maria Van Kerkhove, WHO Technical Lead COVID-19, has been moderated by Aleksandra Kuzmanovic who also transmitted experiences from various persons around the world....
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Coronavirus Infections/diagnosis, Pneumonia, Viral/diagnosis, Epidemiological Monitoring, Influenza, Human/immunology, Influenza, Human/diagnosis, Influenza, Human/transmission, Influenza Vaccines/immunology, Vaccination Coverage/supply & distribution, Health Policy, Risk Groups, Virus Shedding, Social Isolation, Masks, Air Pollution, Indoor/prevention & control, Health Promotion, Coronavirus Infections/complications, Pneumonia, Viral/complications, Maternal and Child Health, COVID-19
Media briefing on COVID-19 - 16/10/2020
Date:
16/10/2020
See more details
Betacoronavirus/immunology, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Epidemiological Monitoring, Health Systems/organization & administration, Coronavirus Infections/drug therapy, Pneumonia, Viral/drug therapy, Chloroquine/therapeutic use, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Clinical Protocols, Dexamethasone/therapeutic use, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/immunology, Clinical Trial, Health Equity, Americas/epidemiology, Social Isolation, Masks, Hospital Bed Capacity, Intensive Care Units, Influenza, Human/immunology, Influenza Vaccines/immunology, Risk Groups, Health Promotion, Hypertension/prevention & control, COVID-19, Ghebreyesus, Tedros Adhanom, Covax
Saúde em Pauta 01 Bloco 1
Date:
30/05/2019
Programa exibido na Tv Aperipê 6.1 - 18.05.2019
See more details
Health Promotion, Violence Against Women, Sex Offenses/prevention & control, Child Abuse, Sexual/prevention & control, Immunization Programs/organization & administration, Influenza Vaccines/immunology, Influenza, Human/immunology, Risk Groups, Dengue/prevention & control, Mosquito Vectors
Como são escolhidos os grupos prioritários para a vacina da gripe?
Date:
06/05/2019
Como são escolhidos os grupos prioritários para a vacina da gripe?
Quem responde é a enfermeira responsável pela vigilância da influenza no RS, Letícia Martins.
See more details
Influenza, Human/immunology, Influenza Vaccines/immunology, Health Promotion, Risk Groups
Por que as pessoas com 60 anos ou mais precisam se vacinar contra a gripe?
Date:
06/05/2019
Por que as pessoas com 60 anos ou mais precisam se vacinar contra a gripe?
Quem responde é a presidente da Seccional do RS da Sociedade Brasileira de Geriatria e Gerontologia, João Senger.
See more details
Influenza, Human/immunology, Influenza Vaccines/immunology, Health Promotion, Risk Groups
